Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001968202-24-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-15 | 2024-08-14 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $1,153.15 | -6,363 | 48.6K | -12% | -$7.34M |
| D | 2024-08-15 | 2024-08-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $399.66 | +20.0K | 68.3K | +41% | +$7.99M |
| D | 2024-08-15 | 2024-08-13 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $1,141.49 | -13.6K | 54.7K | -20% | -$15.57M |
| D | 2024-08-15 | 2024-08-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-14 | S | D | 48 | $1,142.94 | 54,566 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-13 | M | A | 20,000 | $399.66 | 68,306 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-13 | F | D | 13,637 | $1,141.49 | 54,669 | D | — | — | |
| 4 | Common | Common Stock | 2024-08-14 | S | D | 55 | $1,140.31 | 54,614 | D | — | — | |
| 5 | Common | Common Stock | 2024-08-14 | S | D | 331 | $1,159.69 | 48,306 | D | — | — | (F14) Represents volume-weighted average price of sales of 331 shares of Company stock on August 14, 2024 at prices ranging from $1,159.21 to $1,159.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-08-14 | S | D | 79 | $1,143.28 | 54,487 | D | — | — | |
| 7 | Common | Common Stock | 2024-08-14 | S | D | 45 | $1,144.89 | 54,442 | D | — | — | |
| 8 | Common | Common Stock | 2024-08-14 | S | D | 148 | $1,145.58 | 54,294 | D | — | — | (F2) Represents volume-weighted average price of sales of 148 shares of Company stock on August 14, 2024 at prices ranging from $1,145.33 to $1,145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-08-14 | S | D | 51 | $1,146.60 | 54,243 | D | — | — | |
| 10 | Common | Common Stock | 2024-08-14 | S | D | 537 | $1,148.52 | 53,706 | D | — | — | (F3) Represents volume-weighted average price of sales of 537 shares of Company stock on August 14, 2024 at prices ranging from $1,148.06 to $1,148.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 11 | Common | Common Stock | 2024-08-14 | S | D | 294 | $1,149.60 | 53,412 | D | — | — | (F4) Represents volume-weighted average price of sales of 294 shares of Company stock on August 14, 2024 at prices ranging from $1,149.13 to $1,149.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 12 | Common | Common Stock | 2024-08-14 | S | D | 844 | $1,150.41 | 52,568 | D | — | — | (F5) Represents volume-weighted average price of sales of 844 shares of Company stock on August 14, 2024 at prices ranging from $1,150.10 to $1,150.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 13 | Common | Common Stock | 2024-08-14 | S | D | 185 | $1,151.46 | 52,383 | D | — | — | (F6) Represents volume-weighted average price of sales of 185 shares of Company stock on August 14, 2024 at prices ranging from $1,151.09 to $1,151.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 14 | Common | Common Stock | 2024-08-14 | S | D | 197 | $1,152.36 | 52,186 | D | — | — | (F7) Represents volume-weighted average price of sales of 197 shares of Company stock on August 14, 2024 at prices ranging from $1,152.27 to $1,152.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 15 | Common | Common Stock | 2024-08-14 | S | D | 987 | $1,153.74 | 51,199 | D | — | — | (F8) Represents volume-weighted average price of sales of 987 shares of Company stock on August 14, 2024 at prices ranging from $1,153.07 to $1,153.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 16 | Common | Common Stock | 2024-08-14 | S | D | 777 | $1,154.66 | 50,422 | D | — | — | (F9) Represents volume-weighted average price of sales of 777 shares of Company stock on August 14, 2024 at prices ranging from $1,154.05 to $1,154.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 17 | Common | Common Stock | 2024-08-14 | S | D | 402 | $1,155.76 | 50,020 | D | — | — | (F10) Represents volume-weighted average price of sales of 402 shares of Company stock on August 14, 2024 at prices ranging from $1,155.04 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 18 | Common | Common Stock | 2024-08-14 | S | D | 1,016 | $1,156.43 | 49,004 | D | — | — | (F11) Represents volume-weighted average price of sales of 1,016 shares of Company stock on August 14, 2024 at prices ranging from $1,156.06 to $1,156.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 19 | Common | Common Stock | 2024-08-14 | S | D | 178 | $1,157.41 | 48,826 | D | — | — | (F12) Represents volume-weighted average price of sales of 178 shares of Company stock on August 14, 2024 at prices ranging from $1,157.13 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 20 | Common | Common Stock | 2024-08-14 | S | D | 189 | $1,158.78 | 48,637 | D | — | — | (F13) Represents volume-weighted average price of sales of 189 shares of Company stock on August 14, 2024 at prices ranging from $1,158.53 to $1,158.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price. |
| 21 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-08-13 | M | D | 20,000 | $0.00 | 0 | D | $399.66 · — to 2024-12-16 | 20,000 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |